Ensol Biosciences Inc. (XKON:140610)
10,170
+80 (0.79%)
At close: Sep 3, 2026
| Market Cap | 146.64B -32.8% |
| Revenue (ttm) | 537.46M +208.9% |
| Net Income | -5.40B |
| EPS | -644.00 |
| Shares Out | 14.38M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,095 |
| Open | 10,100 |
| Previous Close | 10,090 |
| Day's Range | 10,000 - 10,200 |
| 52-Week Range | 8,810 - 17,900 |
| Beta | 0.70 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |